A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Clinical trial NCT03274206 · UNKNOWN
Trial details
- NCT number
- NCT03274206
- Sponsor
- BioLeaders Corporation
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-30
- Primary completion
- 2020-08-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.